FAIR VALUE MEASUREMENTS - Change in Fair Value of Level 3 Fair Value Measurements (Details) - Level 3 |
6 Months Ended |
|---|---|
|
Dec. 31, 2020
USD ($)
| |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
| Level 3 Derivative warrant liabilities at June 24, 2020 (inception) | $ 0 |
| Issuance of Public and Private Warrants | 16,197,500 |
| Transfer to Level 1 measurement - Public Warrants | (10,212,500) |
| Change in fair value of derivative warrant liabilities | 630,000 |
| Level 3 Derivative warrant liabilities at December 31, 2020 | $ 6,615,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Fair value of financial and nonfinancial obligations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|